VERAXA Biotech (VRXA) Stock Price & Financial Analysis
VERAXA Biotech Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About VERAXA Biotech
What is the current stock price for VRXA?
As of the latest trading session, VRXA stock trades at $1.86. The 52-week range is $1.70–$27.36, with a day range of $1.80–$2.04.
What is the P/E ratio for VRXA?
VERAXA Biotech's trailing P/E ratio is 5.5, meaning investors pay $5.5 for every $1 of annual earnings. The forward P/E is 6.9, reflecting analyst expectations for future earnings. VERAXA Biotech operates in the Healthcare sector.
Does VRXA pay dividends?
VERAXA Biotech does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for VRXA?
Analyst ratings and recommendations for VRXA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of VRXA?
VERAXA Biotech's market capitalization is $37.2M, classifying it as a micro-cap company. VERAXA Biotech operates in the Healthcare sector within the Biotechnology industry.